期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌新辅助化疗对局部区域外科治疗策略的影响 被引量：2

下载PDF
导出
摘要 乳腺癌新辅助化疗（neoadjuvant chemotherapy,NAC）是目前治疗乳腺癌,尤其是中晚期乳腺癌的重要治疗手段,NAC不仅可以使原发肿瘤和转移的淋巴结缩小,降低肿瘤临床分期,为无手术条件的患者提供手术的机会,提高保留乳房治疗的安全性;理论上也能抑制或消灭可能存在的微小转移病灶,降低治疗失败的概率,而且还能评估肿瘤对化疗药物的敏感性,从而为后续治疗提供依据。
作者 左文述 郑美珠
机构地区 山东省肿瘤医院外科二病区(乳腺病中心)
出处 《中国肿瘤外科杂志》 CAS 2015年第3期137-140,共4页 Chinese Journal of Surgical Oncology
基金 2014年山东省医学科学院院级科技计划项目(2014-02)
关键词 乳腺癌 新辅助化疗 区域淋巴结 外科治疗
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献24

  • 1刘志勇,李宝江.乳腺癌新辅助化疗中循环肿瘤细胞的动态变化及疗效观察[J].中国肿瘤临床,2013,40(23):1431-1435. 被引量：30
  • 2Spanheimer PM, Cart JC,Thomas A, et al. The response to neoad- juvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer [ J ]. AN J Surg, 2013,206 (1):2-7.
  • 3Fisher B, Brown A, Mamounas E, et al. Thresholds for therapies highlights of the St Gallen International Expert Conensus on the primary therapy of early breast cancer 2009 [ J ]. Ann Oncol, 2009, 20 (80) :1319-1329.
  • 4Mieog JS, vander Hage JA, varde Velde CJ. Neoadjuvant chemo- therapy for operable breast cancer[ J]. Br J Surg,2007,94 (10) : 1189-1200. Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemo hera- py:updates of National Surgical.
  • 5Adjuvant Breast and Bowel Project Protocols B-18 and B-27 [J]. J Clin Oncol, 2008, 26 ( 5 ) : 778-785.
  • 6vander Hage JA, van de Velde CJ, Ju lien JP, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902[J]. J Clin Oncol, 2001,19 (22) :4224-4237.
  • 7Rouzier R, Mathieu MC, Sideris L, et al. Breast-conserving sur- gery after neoadjuvant anthracycline-based chemotherapy for large breast tumors[J]. Cancer, 2004, 101(5) :918-925.
  • 8Nakamura S, Kenjo H, Nishio T, et al. Efficacy of 3D-MRI man- mography for breast conserving surgery after neoadjuvant chemo- therapys [ J ]. Breast cancer,2002,9 ( 1 ) : 15-19.
  • 9杨奔,左文述.乳腺癌新辅助化疗疗效临床影像学评价方法[J].中华内分泌外科杂志,2012,6(2):117-119. 被引量：6
  • 10邱龙华,顾雅佳.乳腺癌新辅助化疗的MRI评价[J].国外医学（临床放射学分册）,2007,30(4):256-260. 被引量：10

二级参考文献119

  • 1<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量：164
  • 2李冬,陈江浩,汪静,凌瑞,姚青,王岭.^(18)F-FDGPET/CT融合显像对乳腺癌新辅助化疗疗效的预测价值[J].癌症,2007,26(8):900-904. 被引量：8
  • 3Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from national surgical adjuvant breast and bowel project B-18[J]. J Clin Oncol, 1997, 15(7): 2483-2493.
  • 4van der Hage JA, van de Velde C J, Julien JP, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for research and treatment of cancer trial 10902[J]. J Clin Oncol, 2001, 19(22): 4224-4237.
  • 5Londero V, Bazzocchi M, Del Frate C, et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy[J]. Eur Radiol, 2004, 14(8): 1371-1379.
  • 6Partridge SC, Gibbs JE, Lu Y, et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy[J]. AJR, 2002, 179(5): 1193-1199.
  • 7Vinnicombe SJ, MacVicar AD, Guy RL, et al. Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation[J]. Radiology, 1996, 198(2): 333-340.
  • 8Helvie MA, Joynt LK, Cody RL, et al. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy [J]. Radiology, 1996, 198(2): 327-332.
  • 9Liberman L, Menell JH. Breast imaging reporting and data system (BI-RADS)[J].Radiol Clin North Am, 2002, 40(3): 409-430.
  • 10Balu-Maestro C, Chapellier C, Bleuse A, et al. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI[J]. Breast Cancer Res Treat, 2002, 72(2): 145-152.

共引文献74

同被引文献37

  • 1邵志敏,沈镇宙,徐兵河,主编.乳腺肿瘤学[M].上海:复旦大学出版社,2013: 24-25.
  • 2Cox CE, Salud CJ, Harrinton MA. The role of selective sentinel lymphnode dissection in breast cancer [J]. Surg Clin North Am, 2000,80(6):1759-1777.
  • 3Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicentertrial of sentinel node biopsy versus standard axillary treatment inoperable breast cancer: the ALMANAC trial [ J]. J Natl Cancer Inst,2006, 98 (9):599-^09.
  • 4Fleissig A, Fallowfield LJ, Langridge Cl, et al. Post-operative armmorbidity and quality of life. Results of the ALMANAC randomised trialcomparing sentinel node biopsy with standard axillary treatment in themanagement of patients with early breast cancer[ J]. Breast Cancer ResTreat,2006,95(3) :279-293.
  • 5Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial [ J ]. Lancet Oncol,2010,11 (10) :927-933.
  • 6Hunt KK, Ballman KV, McCall LM,et al. Factors associated withlocal-regional recurrence after a negative sentinel node dissection :results of the ACOSOG Z0010 reial[ J]. Ann Surg, 2012,256 (3):428436.
  • 7Veronesi U, Paganelli G, Viale G, et al. A randomized comparison ofsentinel-node biopsy with routine axillary dissection in breast cancer[J].N Engl J Med,2003,349(6) :546-553.
  • 8Edge S, Byrd DR, Compton CC, et al. AJCC cancer staging handbook[M].7th ed. Chicago: Springer, 2010:347-376.
  • 9Patani N, Mokbel K. The clinical significance of sentinel lymph nodemicrometastasis in breast cancer [ J ]. Breast Cancer Res Treat, 2009,114 (3) : 393402.
  • 10Chen SL, Hochne FM, Giuliano AE. The prognostic significance ofmicrometastases in breast cancer : a SEER population-based analysis[J]. Ann Surg Oncol,2007,14(12) :3378-3384.

引证文献2

二级引证文献8

中国肿瘤外科杂志
2015年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部